Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Adaptive Phase 3 Study to Evaluate the Efficacy and Safety of Sinecatechins (Defined Extract of Green Tea Leaves) Ointment in Adult Patients With Actinic Keratosis of the Scalp and the Face
Conditions
Interventions
Topical treatment
Locations
1
Germany
Aresus Pharma GmbH
Strausberg, Germany
Start Date
September 4, 2024
Primary Completion Date
March 1, 2026
Completion Date
November 1, 2027
Last Updated
August 22, 2025
Lead Sponsor
Aresus Pharma GmbH
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions